Jörg-Michael Rupp (*), Director Pharma International – Roche (President)
Sabine Bruckner (*), Country Manager Switzerland – Pfizer (Vicepresident)
Stefan Hendriks (*) (**), SVP Head Western European Cluster – Novartis (Vicepresident)
Leila Schwery (*), VP Manufacturing & Technical Operations – Janssen/Johnson & Johnson (Vicepresident)
René P. Buholzer, CEO Interpharma & Delegate of the Board
Myriam DeLeone, General Manager Switzerland – Amgen
Dimitri Gitas, General Manager Switzerland – MSD
Thorsten Hein, Country Division Head Pharmaceuticals – Bayer
Bairbre Hickie (**), General Manager Switzerland – Takeda
Matthias Leuenberger, Country President Switzerland – Novartis
Andrea Michael Meyer, Head Global Supply Chain Strategy & Excellence/VP – Sanofi
Max Pahlow (**), Managing Director Switzerland – Janssen/Johnson & Johnson
Florian Schick, President and General Manager Switzerland – Merck
Nathalie Stieger (**), Head of Group Government Affairs – Roche
Daniel Weber (*), Country Head Switzerland – Boehringer Ingelheim
Anne Mette Wiis Vogelsang (**), CVP and General Manager – Novo Nordisk
Member of the Nomination and Membership Committee (*)
Member of the Finance Board Committee (**)
Employees
Executive management
Media contacts
Introducing Interpharma
Information on our key figures and activities in the financial year 2023
Contact us
More about the tasks and overriding aims of Interpharma
Order and download publications.